Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Zachary Enlo-Scott, Erica Bäckström, Ian Mudway & Ben Forbes. (2021) Drug metabolism in the lungs: opportunities for optimising inhaled medicines. Expert Opinion on Drug Metabolism & Toxicology 17:5, pages 611-625.
Read now
Read now
Ursula Gundert-Remy, Ulrike Bernauer, Brunhilde Blömeke, Barbara Döring, Eric Fabian, Carsten Goebel, Stefanie Hessel, Christine Jäckh, Alfonso Lampen, Franz Oesch, Ernst Petzinger, Wolfgang Völkel & Peter H. Roos. (2014) Extrahepatic metabolism at the body's internal–external interfaces. Drug Metabolism Reviews 46:3, pages 291-324.
Read now
Read now
YUESHENG ZHANG. (2013) Understanding the Gender Disparity in Bladder Cancer Risk: The Impact of Sex Hormones and Liver on Bladder Susceptibility to Carcinogens. Journal of Environmental Science and Health, Part C 31:4, pages 287-304.
Read now
Read now
Hiroshi Maeda, Hiroshi Kodaira, Kazuhiro Fujita, Hiroyuki Kobayashi, Junko Ushiki, Takeo Nakanishi & Ikumi Tamai. (2012) Species differences in the pharmacokinetics of KW-7158 [(2S)-(+)-3,3,3-Trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide]: formation of hydrolyzed metabolite in human and animals. Xenobiotica 42:7, pages 649-659.
Read now
Read now
Diansong Zhou, Minli Zhang, Xiaomei Ye, Chungang Gu, Timothy M. Piser, Bernard A. Lanoue, Sara A. Schock, Yi-Fang Cheng & Scott W. Grimm. (2011) In vitro metabolism of α7 neuronal nicotinic receptor agonist AZD0328 and enzyme identification for its N-oxide metabolite. Xenobiotica 41:3, pages 232-242.
Read now
Read now
H. M. Korashy, R. H. Elbekai & A. O. S. El-Kadi. (2004) Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review. Xenobiotica 34:1, pages 1-29.
Read now
Read now
Joshua T. Cohen, Gary Carlson, Gail Charnley, David Coggon, Elizabeth Delzell, John D. Graham, Helmut Greim, Daniel Krewski, Michele Medinsky, Richard Monson, Dennis Paustenbach, Barbara Petersen, Stephen Rappaport, Lorenz Rhomberg, P. Barry Ryan & Kimberly Thompson. (2002) A COMPREHENSIVE EVALUATION OF THE POTENTIAL HEALTH RISKS ASSOCIATED WITH OCCUPATIONAL AND ENVIRONMENTAL EXPOSURE TO STYRENE. Journal of Toxicology and Environmental Health, Part B 5:1-2, pages 1-263.
Read now
Read now
R. De Kanter, M. H. De Jager, A. L. Draaisma, J. U. Jurva, P. Olinga, D. K. F. Meijer & G. M. M. Groothuis. (2002) Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slices. Xenobiotica 32:5, pages 349-362.
Read now
Read now
V. RODILLA*A. A. BENZIE, J. M. VEITCH, G. I. MURRAY, J. D. ROWE & G. M. HAWKSWORTH. (1998) Glutathione S-transferases in human renal cortex and neoplastic tissue : enzymatic activity, isoenzyme profile and immunohistochemical localization. Xenobiotica 28:5, pages 443-456.
Read now
Read now
M. VARGAS & M. R. FRANKLIN*. (1997) Intestinal UDP-glucuronosyltransferase activities in rat and rabbit. Xenobiotica 27:5, pages 413-421.
Read now
Read now
Heidi Foth. (1995) Role of the Lung in Accumulation and Metabolism of Xenobiotic Compounds — Implications for Chemically Induced Toxicity. Critical Reviews in Toxicology 25:2, pages 165-205.
Read now
Read now
G. M. Pacifici, P. Romiti, S. Santerini & L. Giuliani. (1993) S-methyltransferases in human intestine: differential distribution of the microsomal thiol methyltransferase and cytosolic thiopurine methyltransferase along the human bowel. Xenobiotica 23:6, pages 671-679.
Read now
Read now
A. Temellini, M. Franchi, L. Giuliani & G. M. Pacifici. (1991) Human liver sulphotransferase and UDP-glucuronosyltransferase: Structure-activity relationship for phenolic substrates. Xenobiotica 21:2, pages 171-177.
Read now
Read now
Articles from other publishers (96)
Stephani L. Stancil, Robin E. Pearce, Vincent S. Staggs & J. Steven Leeder. (2023) Ontogeny of Scaling Factors for Pediatric Physiologically Based Pharmacokinetic Modeling and Simulation: Cytosolic Protein Per Gram of Liver. Drug Metabolism and Disposition 51:12, pages 1578-1582.
Crossref
Crossref
Min-Seok Yang, Ji-Hyun Kang, Dong-Wook Kim & Chun-Woong Park. (2023) Recent developments in dry powder inhalation (DPI) formulations for lung-targeted drug delivery. Journal of Pharmaceutical Investigation.
Crossref
Crossref
Kevin McNally, Craig Sams & George Loizou. (2023) Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using in silico, in vitro and human biomonitoring data. Frontiers in Pharmacology 14.
Crossref
Crossref
Kevin McNally, Craig Sams, Alex Hogg & George Loizou. (2023) Development, testing, parameterisation, and calibration of a human PBPK model for the plasticiser, di-(2-ethylhexyl) terephthalate (DEHTP) using in silico, in vitro and human biomonitoring data. Frontiers in Pharmacology 14.
Crossref
Crossref
Janka Vašková, Ladislav Kočan, Ladislav Vaško & Pál Perjési. (2023) Glutathione-Related Enzymes and Proteins: A Review. Molecules 28:3, pages 1447.
Crossref
Crossref
Kevin McNally & George Loizou. (2023) Refinement and calibration of a human PBPK model for the plasticiser, Di-(2-propylheptyl) phthalate (DPHP) using in silico, in vitro and human biomonitoring data. Frontiers in Pharmacology 14.
Crossref
Crossref
Adam S. Darwich, Oliver J. Hatley, Andrés Olivares‐Morales, Farzaneh Salem, Alison Margolskee & Amin Rostami‐Hodjegan. 2022. Oral Drug Delivery for Modified Release Formulations. Oral Drug Delivery for Modified Release Formulations
65
86
.
George Loizou, Kevin McNally, Alicia Paini & Alex Hogg. (2022) Derivation of a Human In Vivo Benchmark Dose for Bisphenol A from ToxCast In Vitro Concentration Response Data Using a Computational Workflow for Probabilistic Quantitative In Vitro to In Vivo Extrapolation. Frontiers in Pharmacology 12.
Crossref
Crossref
Aditya R. Kumar, Bhagwat Prasad, Deepak Kumar Bhatt, Sumathy Mathialagan, Manthena V. S. Varma & Jashvant D. Unadkat. (2021) In Vitro–to–In Vivo Extrapolation of Transporter-Mediated Renal Clearance: Relative Expression Factor Versus Relative Activity Factor Approach. Drug Metabolism and Disposition 49:6, pages 470-478.
Crossref
Crossref
Rachel Yoon Kyung Chang, Michael Y.T. Chow, Dipesh Khanal, Donghao Chen & Hak-Kim Chan. (2021) Dry powder pharmaceutical biologics for inhalation therapy. Advanced Drug Delivery Reviews 172, pages 64-79.
Crossref
Crossref
Michael J. Doerksen, Robert S. Jones, Michael W. H. Coughtrie & Abby C. Collier. (2020) Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation. European Journal of Drug Metabolism and Pharmacokinetics 46:2, pages 173-183.
Crossref
Crossref
Hana Douafer, Véronique Andrieu & Jean Michel Brunel. (2020) Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases. Journal of Controlled Release 325, pages 276-292.
Crossref
Crossref
Fereshteh Bayat, Reza Hosseinpour-Moghadam, Fatemeh Mehryab, Yousef Fatahi, Niayesh Shakeri, Rassoul Dinarvand, Timo L.M. Ten Hagen & Azadeh Haeri. (2020) Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation. Advances in Colloid and Interface Science 277, pages 102121.
Crossref
Crossref
F. Oesch, E. Fabian & Robert Landsiedel. (2019) Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models. Archives of Toxicology 93:12, pages 3419-3489.
Crossref
Crossref
Kevin McNally, Craig Sams & George Loizou. (2019) Development, Testing, Parameterization, and Calibration of a Human Physiologically Based Pharmacokinetic Model for the Plasticizer, Hexamoll® Diisononyl-Cyclohexane-1, 2-Dicarboxylate Using In Silico, In Vitro, and Human Biomonitoring Data. Frontiers in Pharmacology 10.
Crossref
Crossref
Yildiz Yilmaz, Gareth Williams, Markus Walles, Nenad Manevski, Stephan Krähenbühl & Gian Camenisch. (2019) Comparison of Rat and Human Pulmonary Metabolism Using Precision-cut Lung Slices (PCLS). Drug Metabolism Letters 13:1, pages 53-63.
Crossref
Crossref
Nagarjun Rangaraj, Sravanthi Reddy Pailla & Sunitha Sampathi. (2019) Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements. Pulmonary Pharmacology & Therapeutics 54, pages 1-21.
Crossref
Crossref
Lisha Xiang & Gregg L. Semenza. 2019. Cancer Stem Cells. Cancer Stem Cells
175
212
.
Amanda M. Kleiman & Keith E. Littlewood. 2019. Principles and Practice of Anesthesia for Thoracic Surgery. Principles and Practice of Anesthesia for Thoracic Surgery
131
149
.
Edita Baltruskeviciene, Birutė Kazbariene, Eduardas Aleknavicius, Aurelija Krikstaponiene, Lina Venceviciene, Kestutis Suziedelis, Eugenijus Stratilatovas & Janina Didziapetriene. (2018) Changes of reduced glutathione and glutathione S-transferase levels in colorectal cancer patients undergoing treatment. Tumori Journal 104:5, pages 375-380.
Crossref
Crossref
J.Y. Cui & C.Y. Li. 2018. Comprehensive Toxicology. Comprehensive Toxicology
168
214
.
Oliver J.D. Hatley, Christopher R. Jones, Aleksandra Galetin & Amin Rostami‐Hodjegan. (2017) Quantifying gut wall metabolism: methodology matters. Biopharmaceutics & Drug Disposition 38:2, pages 155-160.
Crossref
Crossref
Daniel Scotcher, Christopher Jones, Maria Posada, Amin Rostami-Hodjegan & Aleksandra Galetin. (2016) Key to Opening Kidney for In Vitro–In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data. The AAPS Journal 18:5, pages 1067-1081.
Crossref
Crossref
Sheila Annie Peters, Christopher R. Jones, Anna-Lena Ungell & Oliver J. D. Hatley. (2016) Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models. Clinical Pharmacokinetics 55:6, pages 673-696.
Crossref
Crossref
Khalid O Alfarouk, Christian-Martin Stock, Sophie Taylor, Megan Walsh, Abdel Khalig Muddathir, Daniel Verduzco, Adil H H Bashir, Osama Y Mohammed, Gamal O Elhassan, Salvador Harguindey, Stephan J Reshkin, Muntaser E Ibrahim & Cyril Rauch. (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell International 15:1.
Crossref
Crossref
Rahul K. Verma, Mariam Ibrahim & Lucila Garcia‐Contreras. 2015. Pulmonary Drug Delivery. Pulmonary Drug Delivery
1
18
.
Yoshihiro Shibata & Masato Chiba. (2015) The Role of Extrahepatic Metabolism in the Pharmacokinetics of the Targeted Covalent Inhibitors Afatinib, Ibrutinib, and Neratinib. Drug Metabolism and Disposition 43:3, pages 375-384.
Crossref
Crossref
Na Ye, Minghai Tang, Haoyu Ye, Chunyan Wang, Chunyu Wang, Qiunan Yang, Li Wan & Lijuan Chen. (2015)
13
C stable isotope labeling followed by ultra-high performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry (UHPLC/Q-TOF MS) was applied to identify the metabolites of honokiol in rat small intestines
. Analytical Methods 7:6, pages 2488-2496.
Crossref
Crossref
Seho Park, Young-Jun Kim & Sangyong Jon. (2014) A high-affinity peptide for nicotinic acetylcholine receptor-α1 and its potential use in pulmonary drug delivery. Journal of Controlled Release 192, pages 141-147.
Crossref
Crossref
Emma E. Ramsay & Pierre J. Dilda. (2014) Glutathione S-conjugates as prodrugs to target drug-resistant tumors. Frontiers in Pharmacology 5.
Crossref
Crossref
M.V. Fanucchi. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Michelle V. Fanucchi. 2014. The Lung. The Lung
223
231
.
B.S. Raccor, A.M. Teitelbaum, J.C. Dinh & R.A. Totah. 2014. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Katherine L. Tuggle & Michelle V. Fanucchi. 2014. Mitochondrial Function in Lung Health and Disease. Mitochondrial Function in Lung Health and Disease
177
214
.
Paolo Ruzza & Andrea Calderan. (2013) Glutathione Transferase (GST)-Activated Prodrugs. Pharmaceutics 5:4, pages 220-231.
Crossref
Crossref
Alexander V. LyubimovShalu Jhajra, Ninad Ramesh Varkhede, Deepak Suresh Ahire, Bukke Vidyasagar Naik, Bhagwat Prasad, Jyoti Paliwal & Saranjit Singh. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
99
.
Ralph W. Niven. (2011) Toward managing chronic rejection after lung transplant: The fate and effects of inhaled cyclosporine in a complex environment. Advanced Drug Delivery Reviews 63:1-2, pages 88-109.
Crossref
Crossref
Lauren Yeazell & Keith Littlewood. 2011. Principles and Practice of Anesthesia for Thoracic Surgery. Principles and Practice of Anesthesia for Thoracic Surgery
103
119
.
Kirstin Thelen & Jennifer B Dressman. (2009) Cytochrome P450-mediated metabolism in the human gut wall. Journal of Pharmacy and Pharmacology 61:5, pages 541-558.
Crossref
Crossref
R.I. Sanchez & F.C. Kauffman. 2010. Comprehensive Toxicology. Comprehensive Toxicology
109
128
.
M.V. Fanucchi. 2010. Comprehensive Toxicology. Comprehensive Toxicology
199
221
.
Takashi Mizuma. (2008) Assessment of Presystemic and Systemic Intestinal Availability of Orally Administered Drugs Using In Vitro and In Vivo Data in Humans: Intestinal Sulfation Metabolism Impacts Presystemic Availability Much More Than Systemic Availability of Salbutamol, SULT1A3 Substrate. Journal of Pharmaceutical Sciences 97:12, pages 5471-5476.
Crossref
Crossref
Christopher Kohl. 2008. Drug Bioavailability. Drug Bioavailability
333
357
.
Esther G. van de Kerkhof, Inge A. M. de Graaf, Anna-Lena B. Ungell & Geny M. M. Groothuis. (2008) Induction of Metabolism and Transport in Human Intestine: Validation of Precision-Cut Slices as a Tool to Study Induction of Drug Metabolism in Human Intestine in Vitro. Drug Metabolism and Disposition 36:3, pages 604-613.
Crossref
Crossref
R H M te Morsche, J P H Drenth, K Truninger, H-U Schulz, A Kage, O Landt, M Verlaan, J Rosendahl, M MacekJrJr, J B M J Jansen & H Witt. (2007) UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls. The Pharmacogenomics Journal 8:1, pages 34-41.
Crossref
Crossref
G. I. Somers, N. Lindsay, B. M. Lowdon, A. E. Jones, C. Freathy, S. Ho, A. J. M. Woodrooffe, M. K. Bayliss & G. R. Manchee. (2007) A Comparison of the Expression and Metabolizing Activities of Phase I and II Enzymes in Freshly Isolated Human Lung Parenchymal Cells and Cryopreserved Human Hepatocytes. Drug Metabolism and Disposition 35:10, pages 1797-1805.
Crossref
Crossref
R.A. Totah & A.E. Rettie. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
167
191
.
Jennifer L. Donovan, Claudine Manach, Richard M. Faulks & Paul A. Kroon. 2006. Plant Secondary Metabolites. Plant Secondary Metabolites
303
351
.
Gwo-Tzer Ho, Daniel R Gaya & Jack Satsangi. (2005) Multidrug Resistance (MDR1) Gene in Inflammatory Bowel Disease: A Key Player?. Inflammatory Bowel Diseases 11:11, pages 1013-1019.
Crossref
Crossref
Michael J. Blake, Lisa Castro, J. Steven Leeder & Gregory L. Kearns. (2005) Ontogeny of drug metabolizing enzymes in the neonate. Seminars in Fetal and Neonatal Medicine 10:2, pages 123-138.
Crossref
Crossref
Smarajit Maiti, Sangita Maiti Dutta, Sharon M. Baker, Jimei Zhang, Telugu Narasaraju, Lin Liu & Guangping Chen. (2005) In vivo and in vitro oxidative regulation of rat aryl sulfotransferase IV (AST IV). Journal of Biochemical and Molecular Toxicology 19:2, pages 109-118.
Crossref
Crossref
Smarajit Maiti, Xinrong Chen & Guangping Chen. (2005) All-trans Retinoic Acid Induction of Sulfotransferases. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 96:1, pages 44-53.
Crossref
Crossref
Chin-Chung Lin, Li-Tain Yeh, Domenico Vitarella, Zhi Hong & Mark D Erion. (2016) Remofovir Mesylate: A Prodrug of PMEA with Improved Liver-Targeting and Safety in Rats and Monkeys. Antiviral Chemistry and Chemotherapy 15:6, pages 307-317.
Crossref
Crossref
Smarajit Maiti, Shannon Grant, Sharon M. Baker, Subramanya Karanth, Carey N. Pope & Guangping Chen. (2004) Stress regulation of sulfotransferases in male rat liver. Biochemical and Biophysical Research Communications 323:1, pages 235-241.
Crossref
Crossref
Thomas Langmann, Christoph Moehle, Richard Mauerer, Michael Scharl, Gerhard Liebisch, Alexandra Zahn, Wolfgang Stremmel & Gerd Schmitz. (2004) Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 127:1, pages 26-40.
Crossref
Crossref
Mariette Verlaan, Ren?? HM te Morsche, Akos Pap, Robert JF Laheij, Jan BMJ Jansen, Wilbert HM Peters & Joost PH Drenth. (2004) Functional polymorphisms of UDP-glucuronosyltransferases 1A1, 1A6 and 1A8 are not involved in chronic pancreatitis. Pharmacogenetics 14:6, pages 351-357.
Crossref
Crossref
Martijn Rooseboom, Jan N. M. Commandeur & Nico P. E. Vermeulen. (2004) Enzyme-Catalyzed Activation of Anticancer Prodrugs. Pharmacological Reviews 56:1, pages 53-102.
Crossref
Crossref
Michelle V. Fanucchi. 2004. The Lung. The Lung
177
185
.
Suoping Zhai. 2004. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
363
371
.
Leizhen Zheng, Yunfei Wang, Matthew B Schabath, H.Barton Grossman & Xifeng Wu. (2003) Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study. Cancer Letters 202:1, pages 61-69.
Crossref
Crossref
Xiao Wei Teng, David J. Cutler & Neal M. Davies. (2003) Mometasone furoate degradation and metabolism in human biological fluids and tissues. Biopharmaceutics & Drug Disposition 24:8, pages 321-333.
Crossref
Crossref
Y. Tsuneoka, T. P. Dalton, M. L. Miller, C. D. Clay, H. G. Shertzer, G. Talaska, M. Medvedovic & D. W. Nebert. (2003) 4-Aminobiphenyl-Induced Liver and Urinary Bladder DNA Adduct Formation in Cyp1a2(-/-) and Cyp1a2(+/+) Mice. JNCI Journal of the National Cancer Institute 95:16, pages 1227-1237.
Crossref
Crossref
Smarajit Maiti & Guangping Chen. (2003) Tamoxifen Induction of Aryl Sulfotransferase and Hydroxysteroid Sulfotransferase in Male and Female Rat Liver and Intestine. Drug Metabolism and Disposition 31:5, pages 637-644.
Crossref
Crossref
Kian Hong Ng, Beng Gek Lim & Kim Ping Wong. (2003) Sulfate conjugating and transport functions of MDCK distal tubular cells. Kidney International 63:3, pages 976-986.
Crossref
Crossref
Jiro Kajita, Eiichi Fuse, Takashi Kuwabara & Hiroyuki Kobayashi. (2003) The Contribution of Cytochrome P450 to the Metabolism of Tegafur in Human Liver. Drug Metabolism and Pharmacokinetics 18:5, pages 303-309.
Crossref
Crossref
Wilbert H.M Peters, Rene H.M te Morsche & Hennie M.J Roelofs. (2003) Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome. Journal of Hepatology 38:1, pages 3-8.
Crossref
Crossref
M. G. Soars, B. Burchell & R. J. Riley. (2002) In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance. Journal of Pharmacology and Experimental Therapeutics 301:1, pages 382-390.
Crossref
Crossref
Johannes G. Filser, Winfried Kessler & György A. Csanády. (2002) Estimation of a possible tumorigenic risk of styrene from daily intake via food and ambient air. Toxicology Letters 126:1, pages 1-18.
Crossref
Crossref
Jiunn H Lin & Anthony YH Lu. (2001) Interindividual Variability in Inhibition and Induction of Cytochrome P450 Enzymes. Annual Review of Pharmacology and Toxicology 41:1, pages 535-567.
Crossref
Crossref
Laura Giuliani, Paola Gazzaniga, Francesca Caporuscio, Marco Ciotti, Luigi Frati & Anna Maria Aglian�. (2001) Can down-regulation of UDP-glucuronosyltransferases in the urinary bladder tissue impact the risk of chemical carcinogenesis?. International Journal of Cancer 91:1, pages 141-143.
Crossref
Crossref
Michael B. Fisher, Mark VandenBranden, Karen Findlay, Brian Burchell, Kenneth E. Thummel, Stephen D. Hall & Steven A. Wrighton. (2000) Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank. Pharmacogenetics 10:8, pages 727-739.
Crossref
Crossref
Robert H. TukeyChristian P. Strassburg. (2000) Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease. Annual Review of Pharmacology and Toxicology 40:1, pages 581-616.
Crossref
Crossref
E.S.C Kwok, B.A Buchholz, J.S Vogel, K.W Turteltaub & D.A Eastmond. (1999) Dose-Dependent Binding of ortho-Phenylphenol to Protein but Not DNA in the Urinary Bladder of Male F344 Rats. Toxicology and Applied Pharmacology 159:1, pages 18-24.
Crossref
Crossref
Rn Upton & Dj Doolette. (2004) KINETIC ASPECTS OF DRUG DISPOSITION IN THE LUNGS. Clinical and Experimental Pharmacology and Physiology 26:5-6, pages 381-391.
Crossref
Crossref
Laurence Barthe, John Woodley & Georges Houin. (2009) Gastrointestinal absorption of drugs: methods and studies. Fundamental & Clinical Pharmacology 13:2, pages 154-168.
Crossref
Crossref
Behnaz Mojarrabi & Peter I. Mackenzie. (1998) Characterization of Two UDP Glucuronosyltransferases That Are Predominantly Expressed in Human Colon. Biochemical and Biophysical Research Communications 247:3, pages 704-709.
Crossref
Crossref
E. ALISON EATON, U. KRISTINA WALLE, HUGH M. WILSON, GUNNAR ABERG & THOMAS WALLE. (2008) Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. British Journal of Clinical Pharmacology 41:3, pages 201-206.
Crossref
Crossref
Thomas Walle, E. Alison Eaton, U. Kristina Walle & Gene R. Pesola. (1996) Stereoselective metabolism ofRS-albuterol in humans. Clinical Reviews in Allergy & Immunology 14:1, pages 101-113.
Crossref
Crossref
José Vergés, Lucie Héroux, Hélène Maurice & Patrick du Souich. (2012) Extrahepatic metabolism of frusemide in anaesthetized rabbits. British Journal of Pharmacology 116:5, pages 2407-2412.
Crossref
Crossref
M. Lázníček & A. Lázníčková. (1994) Kidney and liver contributions to salicylate metabolism in rats. European Journal of Drug Metabolism and Pharmacokinetics 19:1, pages 21-26.
Crossref
Crossref
M.S. O'Mahony & K.W. Woodhouse. (1994) Age, environmental factors and drug metabolism. Pharmacology & Therapeutics 61:1-2, pages 279-287.
Crossref
Crossref
D. J. Clarke & B. Burchell. 1994. Conjugation—Deconjugation Reactions in Drug Metabolism and Toxicity. Conjugation—Deconjugation Reactions in Drug Metabolism and Toxicity
3
43
.
Alan L. Mendrala, Patrick W. Langvardt, Kenneth D. Nitschke, John F. Quast & Richard J. Nolan. (1993) In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human. Archives of Toxicology 67:1, pages 18-27.
Crossref
Crossref
Joseph A. Hypolite, Penelope A. Longhurst, Chaoliang Gong, Janice Briscoe, Alan J. Wein & Robert M. Levin. (1993) Metabolic studies on rabbit bladder smooth muscle and mucosa. Molecular and Cellular Biochemistry 125:1, pages 35-42.
Crossref
Crossref
F F KadlubarM A ButlerK R KaderlikH C ChouN P Lang. (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.. Environmental Health Perspectives 98, pages 69-74.
Crossref
Crossref
Stefano Petruzzelli, Marina Franchi, Luca Gronchi, Alberto Janni, Franz Oesch, Gian Maria Pacifici & Carlo Giuntini. (2016) Cigarette Smoke Inhibits Cytosolic but not Microsomal Epoxide Hydrolase of Human Lung. Human & Experimental Toxicology 11:2, pages 99-103.
Crossref
Crossref
David W. Hein, Timothy D. Rustan, William J. Martin, Kyle D. Bucher, Linda S. Miller & Erik J. Furman. (1992) Acetylator genotype-dependent N-acetylation of arylamines in vivo and in vitro by hepatic and extrahepatic organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus. Archives of Toxicology 66:2, pages 112-117.
Crossref
Crossref
F. Peter Guengerich. (1992) Metabolic activation of carcinogens. Pharmacology & Therapeutics 54:1, pages 17-61.
Crossref
Crossref
M. Cappiello, L. Giuliani & G. M. Pacifici. (1991) Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5?-diphosphoglucuronic acid in human tissues. European Journal of Clinical Pharmacology 41:4, pages 345-350.
Crossref
Crossref
Clyde W. Wheeler & Thomas M. Guenthner. (2006) Cytochrome P‐450‐dependent metabolism of xenobiotics in human lung. Journal of Biochemical Toxicology 6:3, pages 163-169.
Crossref
Crossref
P.G. Gervasi, V. Longo, F. Naldi, G. Panattoni & F. Ursino. (1991) Xenobiotic-metabolizing enzymes in human respiratory nasal mucgsa. Biochemical Pharmacology 41:2, pages 177-184.
Crossref
Crossref
GM Pacifici, A Viani, M Franchi, S Santerini, A Temellini, L Giuliani & M Carrai. (2012) Conjugation pathways in liver disease.. British Journal of Clinical Pharmacology 30:3, pages 427-435.
Crossref
Crossref
A. Viani, A. Temellini, G. Tusini & G.M. Pacifici. (2016) Human Brain Sulphotransferase and Glucuronyltransferase. Human & Experimental Toxicology 9:2, pages 65-69.
Crossref
Crossref
A. Ueki, J. Willoughby, Vivette Glover & M. Sandler. (1989) Distribution of phenolsulphotransferase and monoamine oxidase in the common marmoset. Biochemical Pharmacology 38:14, pages 2383-2385.
Crossref
Crossref
M. Cappiello, M. Franchi, L. Giuliani & G. M. Pacifici. (1989) Distribution of 2-naphthol sulphotransferase and its endogenous substrate adenosine 3?-phosphate 5?-phosphosulphate in human tissues. European Journal of Clinical Pharmacology 37:3, pages 317-320.
Crossref
Crossref
G. M. Pacifici, A. Temellini, L. Giuliani, A. Rane, H. Thomas & F. Oesch. (1988) Cytosolic epoxide hydrolase in humans: development and tissue distribution. Archives of Toxicology 62:4, pages 254-257.
Crossref
Crossref